| Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients (NCT00050895) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms (NCT00002357) | Hoechst Marion Roussel | |
| A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV (NCT00033163) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater. (NCT00002173) | The Immune Response Corporation | |
| A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome (NCT00002002) | Lederle Laboratories | |
| A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects (NCT00002428) | United Biomedical | |
| Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults (NCT00000904) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma (NCT00002188) | Anderson Clinical Research | |
| A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis (NCT00002169) | Agouron Pharmaceuticals | |
| Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy (NCT00000728) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 (NCT00000885) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia (NCT00002120) | U.S. Bioscience | |
| A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS (NCT00000688) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy. (NCT00002256) | Hoffmann-La Roche | |
| Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination (NCT00006153) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects (NCT00388492) | Bellos, Nicholaos C., M.D. | |
| The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS (NCT00000971) | Abbott | |
| A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia (NCT00002009) | Sandoz | |
| The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node Disease (NCT00002296) | Newport Pharmaceuticals International | |
| A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection (NCT00005572) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis (NCT00002134) | Roche Global Development | |
| A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT (NCT00000686) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. (NCT00002194) | Boehringer Ingelheim | |
| A Comparison of 141W94 and Indinavir in HIV-Infected Patients (NCT00002202) | Glaxo Wellcome | |
| Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults (NCT00043511) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease (NCT00002244) | OXO Chemie | |
| A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009) (NCT00001021) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART) (NCT00076518) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies (NCT00000869) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of DTC in Patients With AIDS and AIDS Related Complex (NCT00002069) | Merieux Institute | |
| Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) (NCT00001041) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Tolerability of the Vaginal Gel PRO 2000/5 (NCT00006207) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Test the Safety of Three Experimental HIV Vaccines (NCT00000946) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers (NCT00000847) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine (NCT00000835) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00002283) | Jacobus Pharmaceutical | |
| Phase I/II Study of Curdlan Sulfate (NCT00002100) | AJI Pharma USA | |
| A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants (NCT00000944) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Optimal Treatment for Kidney Disease in HIV Infected Adults (NCT00089518) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) (NCT00002036) | Abbott | |
| Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination (NCT00006291) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients (NCT00002013) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV) (NCT00002014) | Glaxo Wellcome | |
| Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors (NCT00007449) | Dupont Applied Biosciences | |
| A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers (NCT00000774) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients (NCT00002376) | Merck Sharp & Dohme LLC | |
| Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects (NCT00000882) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients (NCT00001094) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC) (NCT00002255) | Amgen | |
| Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients (NCT00013585) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir (NCT00000985) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex (NCT00000710) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy (NCT00002422) | Harbor Therapeutics | |
| Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component (NCT00000665) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease. (NCT00002115) | Gilead Sciences | |
| Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E (NCT00002094) | Pharmacia and Upjohn | |
| A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children (NCT00000637) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) (NCT00000836) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients (NCT00000991) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy (NCT00000820) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex (NCT00000986) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults (NCT00008489) | PharmaResearch | |
| A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine (NCT00002274) | Bristol-Myers Squibb | |
| A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 (NCT00002137) | Daiichi Pharmaceuticals | |
| A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients (NCT00002400) | Pharmacia and Upjohn | |
| Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy (NCT00050271) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy (NCT00002247) | Hoffmann-La Roche | |
| The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children (NCT00000843) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 200 Mcg of gp120 (CHO) BIOCINE in MF59 Emulsion Versus the Emulsion Control: Three Injections at 0, 1, and 6 Months (NCT00000749) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex (NCT00000976) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. (NCT00000796) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children (NCT00000851) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS (NCT00002181) | Gilead Sciences | |
| The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood (NCT00001115) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102 (NCT00048217) | Trimeris | |
| A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV (NCT00000791) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT) (NCT00002279) | Hoffmann-La Roche | |
| A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia. (NCT00002102) | U.S. Bioscience | |
| Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex (NCT00000657) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Treatment of Psoriasis Using Acitretin in HIV-Positive Patients (NCT00002143) | Hoffmann-La Roche | |